News

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...
Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...
Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...
Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.
The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.
Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...
Several listed companies announced plans to create BNB crypto treasuries recently, including CEA Industries (VAPE), teaming ...
Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...
BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.
Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...
BNB (BNB), formerly known as Binance Coin, edges lower after hitting a new all-time high of $855 at press time on Monday. The ...
Binance Coin (BNB) surged over 7% to a new all-time high of $855, outperforming major cryptocurrencies and extending its lead ...